Free Trial

ARM (ARM) Financials

ARM logo
$402.71 -6.14 (-1.50%)
Closing price 06/2/2026 04:00 PM Eastern
Extended Trading
$408.49 +5.78 (+1.44%)
As of 09:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for ARM

Annual Income Statements for ARM

This table shows ARM's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025 2026
Period end date 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
549 524 306 792 904
Consolidated Net Income / (Loss)
549 524 306 792 904
Net Income / (Loss) Continuing Operations
676 524 306 792 904
Total Pre-Tax Income
786 671 212 720 1,157
Total Operating Income
633 671 111 831 900
Total Gross Profit
2,572 2,573 3,079 3,886 4,799
Total Revenue
2,703 2,679 3,233 4,007 4,920
Operating Revenue
2,703 2,679 3,233 4,007 4,920
Total Cost of Revenue
131 106 154 121 121
Operating Cost of Revenue
131 106 154 121 121
Total Operating Expenses
1,939 1,902 2,968 3,055 3,899
Selling, General & Admin Expense
897 762 983 984 1,115
Research & Development Expense
995 1,133 1,979 2,071 2,776
Restructuring Charge
26 7.00 6.00 0.00 8.00
Total Other Income / (Expense), net
153 0.00 101 -111 257
Interest & Investment Income
143 -3.00 90 -121 125
Other Income / (Expense), net
10 3.00 11 10 132
Income Tax Expense
110 147 -94 -72 253
Weighted Average Basic Shares Outstanding
1.03B 1.03B 1.03B 1.05B 1.06B
Weighted Average Diluted Shares Outstanding
1.03B 1.03B 1.04B 1.06B 1.07B
Weighted Average Basic & Diluted Shares Outstanding
- - 1.04B 1.06B 1.06B

Quarterly Income Statements for ARM

No quarterly income statements for ARM are available.


Annual Cash Flow Statements for ARM

This table details how cash moves in and out of ARM's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025 2026
Period end date 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents
-210 550 369 162 666
Net Cash From Operating Activities
458 739 1,090 397 1,524
Net Cash From Continuing Operating Activities
458 739 1,090 397 1,524
Net Income / (Loss) Continuing Operations
549 524 306 792 904
Consolidated Net Income / (Loss)
549 524 306 792 904
Depreciation Expense
185 170 162 183 249
Non-Cash Adjustments To Reconcile Net Income
-229 92 755 654 605
Changes in Operating Assets and Liabilities, net
-47 -47 -133 -1,232 -234
Net Cash From Investing Activities
-619 -138 -516 -35 -325
Net Cash From Continuing Investing Activities
-619 -138 -516 -35 -325
Purchase of Property, Plant & Equipment
-34 -64 -92 -219 -545
Acquisitions
-41 -29 -51 -20 -30
Purchase of Investments
-758 -1,126 -797 -737 -1,151
Divestitures
- - 0.00 0.00 127
Sale and/or Maturity of Investments
245 1,081 425 940 1,235
Other Investing Activities, net
-31 0.00 -1.00 1.00 39
Net Cash From Financing Activities
-32 -42 -208 -202 -548
Net Cash From Continuing Financing Activities
-32 -42 -208 -202 -548
Repayment of Debt
-2.00 -2.00 -10 -23 -26
Issuance of Common Equity
- - 0.00 0.00 74
Other Financing Activities, net
-37 -40 -198 -179 -596
Effect of Exchange Rate Changes
-17 -9.00 3.00 2.00 15
Cash Income Taxes Paid
141 157 187 149 223

Quarterly Cash Flow Statements for ARM

No quarterly cash flow statements for ARM are available.


Annual Balance Sheets for ARM

This table presents ARM's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025 2026
Period end date 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets
6,866 7,927 8,932 10,703
Total Current Assets
3,537 4,197 4,830 6,236
Cash & Equivalents
1,554 1,923 2,085 2,751
Short-Term Investments
661 1,000 740 850
Accounts Receivable
999 781 1,107 1,300
Prepaid Expenses
169 157 256 358
Other Current Assets
154 336 642 977
Plant, Property, & Equipment, net
185 215 354 772
Total Noncurrent Assets
3,144 3,515 3,748 3,695
Long-Term Investments
723 741 565 387
Noncurrent Note & Lease Receivables
- 240 40 69
Goodwill
1,620 1,625 1,620 1,623
Intangible Assets
138 152 151 230
Noncurrent Deferred & Refundable Income Taxes
139 282 401 375
Other Noncurrent Operating Assets
524 475 971 1,011
Total Liabilities & Shareholders' Equity
6,866 7,927 8,932 10,703
Total Liabilities
2,815 2,632 2,093 2,417
Total Current Liabilities
1,363 1,505 929 1,040
Current Deferred Revenue
293 198 209 294
Current Deferred & Payable Income Tax Liabilities
162 147 124 106
Current Employee Benefit Liabilities
589 298 140 154
Other Current Liabilities
319 862 456 486
Total Noncurrent Liabilities
1,452 1,107 1,164 1,377
Noncurrent Deferred & Payable Income Tax Liabilities
262 135 41 39
Noncurrent Employee Benefit Liabilities
- - 26 32
Other Noncurrent Operating Liabilities
1,190 255 1,097 1,306
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,051 5,295 6,839 8,286
Total Preferred & Common Equity
4,051 5,295 6,839 8,286
Total Common Equity
4,051 5,295 6,839 8,286
Common Stock
1,218 2,173 2,924 3,469
Retained Earnings
2,457 2,751 3,543 4,447
Accumulated Other Comprehensive Income / (Loss)
376 371 372 370

Quarterly Balance Sheets for ARM

This table presents ARM's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q4 2024
Period end date 3/31/2023 3/31/2024
Total Assets
6,866 7,927
Total Current Assets
3,537 4,197
Cash & Equivalents
1,554 1,923
Short-Term Investments
661 1,000
Accounts Receivable
999 781
Prepaid Expenses
169 157
Other Current Assets
154 336
Plant, Property, & Equipment, net
185 215
Total Noncurrent Assets
3,144 3,515
Long-Term Investments
723 741
Noncurrent Note & Lease Receivables
- 240
Goodwill
1,620 1,625
Intangible Assets
138 152
Noncurrent Deferred & Refundable Income Taxes
139 282
Other Noncurrent Operating Assets
524 475
Total Liabilities & Shareholders' Equity
6,866 7,927
Total Liabilities
2,815 2,632
Total Current Liabilities
1,363 1,505
Current Deferred Revenue
293 198
Current Deferred & Payable Income Tax Liabilities
162 147
Current Employee Benefit Liabilities
589 298
Other Current Liabilities
319 862
Total Noncurrent Liabilities
1,452 1,107
Noncurrent Deferred Revenue
- 717
Noncurrent Deferred & Payable Income Tax Liabilities
262 135
Other Noncurrent Operating Liabilities
1,190 255
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
4,051 5,295
Total Preferred & Common Equity
4,051 5,295
Total Common Equity
4,051 5,295
Common Stock
1,218 2,173
Retained Earnings
2,457 2,751
Accumulated Other Comprehensive Income / (Loss)
376 371

Annual Metrics And Ratios for ARM

This table displays calculated financial ratios and metrics derived from ARM's official financial filings.

Metric 2022 2023 2024 2025 2026
Period end date 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding
- - - - 1,064,055,252.00
DEI Adjusted Shares Outstanding
- - - - 1,064,055,252.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - 0.85
Growth Metrics
- - - - -
Revenue Growth
0.00% -0.89% 20.68% 23.94% 22.79%
EBITDA Growth
0.00% 1.93% -66.35% 260.56% 25.10%
EBIT Growth
0.00% 4.82% -81.90% 589.34% 22.71%
NOPAT Growth
0.00% -3.76% -69.46% 470.91% -23.07%
Net Income Growth
0.00% -4.55% -41.60% 158.82% 14.14%
EPS Growth
0.00% -5.56% -43.14% 0.00% 0.00%
Operating Cash Flow Growth
0.00% 61.35% 47.50% -63.58% 283.88%
Free Cash Flow Firm Growth
0.00% 0.00% 35.82% -133.91% 83.48%
Invested Capital Growth
0.00% 0.00% 48.34% 108.90% 24.62%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - -
Gross Margin
95.15% 96.04% 95.24% 96.98% 97.54%
EBITDA Margin
30.63% 31.50% 8.78% 25.56% 26.04%
Operating Margin
23.42% 25.05% 3.43% 20.74% 18.29%
EBIT Margin
23.79% 25.16% 3.77% 20.99% 20.98%
Profit (Net Income) Margin
20.31% 19.56% 9.46% 19.77% 18.37%
Tax Burden Percent
69.85% 78.09% 144.34% 110.00% 78.13%
Interest Burden Percent
122.24% 99.55% 173.77% 85.61% 112.11%
Effective Tax Rate
13.96% 21.88% -44.25% -10.00% 21.87%
Return on Invested Capital (ROIC)
0.00% 94.20% 11.59% 35.85% 18.15%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 94.21% 7.15% 39.32% 12.71%
Return on Net Nonoperating Assets (RNNOA)
0.00% -68.33% -5.04% -22.79% -6.20%
Return on Equity (ROE)
0.00% 25.87% 6.55% 13.05% 11.95%
Cash Return on Invested Capital (CROIC)
0.00% -105.80% -27.34% -34.66% -3.77%
Operating Return on Assets (OROA)
0.00% 9.82% 1.65% 9.98% 10.51%
Return on Assets (ROA)
0.00% 7.63% 4.14% 9.40% 9.21%
Return on Common Equity (ROCE)
0.00% 25.87% 6.55% 13.05% 11.95%
Return on Equity Simple (ROE_SIMPLE)
0.00% 12.94% 5.78% 11.58% 0.00%
Net Operating Profit after Tax (NOPAT)
545 524 160 914 703
NOPAT Margin
20.15% 19.57% 4.95% 22.81% 14.29%
Net Nonoperating Expense Percent (NNEP)
0.00% -0.01% 4.43% -3.47% 5.44%
Return On Investment Capital (ROIC_SIMPLE)
- - - 13.37% 8.49%
Cost of Revenue to Revenue
4.85% 3.96% 4.76% 3.02% 2.46%
SG&A Expenses to Revenue
33.19% 28.44% 30.41% 24.56% 22.66%
R&D to Revenue
36.81% 42.29% 61.21% 51.68% 56.42%
Operating Expenses to Revenue
71.74% 71.00% 91.80% 76.24% 79.25%
Earnings before Interest and Taxes (EBIT)
643 674 122 841 1,032
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
828 844 284 1,024 1,281
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 1.20 24.66 16.60 19.50
Price to Tangible Book Value (P/TBV)
0.00 2.12 37.11 22.40 25.12
Price to Revenue (P/Rev)
1.80 1.82 40.38 28.33 32.84
Price to Earnings (P/E)
8.87 9.29 426.64 143.33 178.72
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
11.27% 10.76% 0.23% 0.70% 0.56%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.74 76.86 31.93 36.66
Enterprise Value to Revenue (EV/Rev)
0.00 0.72 39.25 27.48 32.03
Enterprise Value to EBITDA (EV/EBITDA)
0.00 2.29 446.79 107.55 123.01
Enterprise Value to EBIT (EV/EBIT)
0.00 2.87 1,040.06 130.95 152.69
Enterprise Value to NOPAT (EV/NOPAT)
0.00 3.69 792.49 120.48 224.09
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 2.62 116.41 277.40 103.40
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -0.73 -0.70 -0.58 -0.49
Leverage Ratio
0.00 1.69 1.58 1.39 1.30
Compound Leverage Factor
0.00 1.69 2.75 1.19 1.46
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 2.63 31.11 34.38 42.05
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - -
Current Ratio
0.00 2.60 2.79 5.20 6.00
Quick Ratio
0.00 2.36 2.46 4.23 4.71
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -589 -378 -884 -146
Operating Cash Flow to CapEx
1,347.06% 1,154.69% 1,184.78% 181.28% 279.63%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.39 0.44 0.48 0.50
Accounts Receivable Turnover
0.00 2.68 3.63 4.24 4.09
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 14.48 16.17 13.16 8.74
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 136.11 100.48 85.99 89.28
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 136.11 100.48 85.99 89.28
Capital & Investment Metrics
- - - - -
Invested Capital
0.00 1,113 1,651 3,449 4,298
Invested Capital Turnover
0.00 4.81 2.34 1.57 1.27
Increase / (Decrease) in Invested Capital
0.00 1,113 538 1,798 849
Enterprise Value (EV)
0.00 1,933 126,888 110,128 157,579
Market Capitalization
4,871 4,871 130,552 113,518 161,567
Book Value per Share
$0.00 $3.95 $5.15 $6.57 $7.84
Tangible Book Value per Share
$0.00 $2.24 $3.42 $4.87 $6.09
Total Capital
0.00 4,051 5,295 6,839 8,286
Total Debt
0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -2,938 -3,664 -3,390 -3,988
Capital Expenditures (CapEx)
34 64 92 219 545
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -41 -231 1,076 1,595
Debt-free Net Working Capital (DFNWC)
0.00 2,174 2,692 3,901 5,196
Net Working Capital (NWC)
0.00 2,174 2,692 3,901 5,196
Net Nonoperating Expense (NNE)
-4.35 0.20 -146 122 -201
Net Nonoperating Obligations (NNO)
0.00 -2,938 -3,644 -3,390 -3,988
Total Depreciation and Amortization (D&A)
185 170 162 183 249
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -1.53% -7.15% 26.85% 32.42%
Debt-free Net Working Capital to Revenue
0.00% 81.15% 83.27% 97.35% 105.61%
Net Working Capital to Revenue
0.00% 81.15% 83.27% 97.35% 105.61%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.30 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.03B 1.05B 1.06B
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.29 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.04B 1.06B 1.07B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.04B 1.06B 1.06B
Normalized Net Operating Profit after Tax (NOPAT)
585 530 82 582 709
Normalized NOPAT Margin
21.65% 19.77% 2.53% 14.52% 14.42%
Pre Tax Income Margin
29.08% 25.05% 6.56% 17.97% 23.52%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
7.83% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
7.83% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for ARM

No quarterly metrics and ratios for ARM are available.



Financials Breakdown Chart

Key Financial Trends

ARM’s balance sheet improved meaningfully in fiscal 2024, with stronger liquidity, higher equity, and a lower liability load relative to assets. For retail investors, that generally points to a more resilient financial position, even though the company still carries a sizable amount of liabilities and goodwill.

  • Cash and short-term investments increased sharply. Cash and equivalents rose to $1.92 billion from $1.55 billion, while short-term investments grew to $1.00 billion from $661 million, boosting near-term financial flexibility.
  • Total current assets expanded at a healthy pace. Current assets climbed to $4.20 billion from $3.54 billion, reflecting stronger overall liquidity.
  • Shareholders’ equity jumped significantly. Total common equity increased to $5.30 billion from $4.05 billion, a strong sign that the company’s net financial position improved over the year.
  • Total assets increased materially. Assets rose to $7.93 billion from $6.87 billion, suggesting continued balance sheet growth.
  • Liabilities grew more slowly than equity and assets. Total liabilities increased modestly to $2.63 billion from $2.82 billion, while equity grew much faster, improving the company’s capitalization profile.
  • Net working capital strengthened. Current assets exceeded current liabilities by $2.69 billion in 2024, versus $2.17 billion in 2023, leaving ARM in a stronger short-term position.
  • Retained earnings improved. Retained earnings rose to $2.75 billion from $2.46 billion, which generally signals accumulated profitability over time.
  • Long-term investments remained substantial. ARM held $741 million in long-term investments, slightly above the prior year, providing an additional cushion.
  • Goodwill remains a large asset component. Goodwill was $1.63 billion, nearly unchanged from 2023, so a meaningful portion of assets still comes from acquisitions rather than hard assets.
  • Accounts receivable declined, which could reflect weaker collections or timing changes. Receivables fell to $781 million from $999 million.
  • Current deferred revenue dropped. Current deferred revenue decreased to $198 million from $293 million, which may indicate less near-term revenue already booked in advance.
  • Noncurrent operating liabilities remain significant. Even after improvement, ARM still carries $1.11 billion in noncurrent liabilities, which investors should continue to monitor.

Bottom line: ARM entered fiscal 2024 with a stronger balance sheet than it had in fiscal 2023. The biggest positives are higher cash, larger investment holdings, and a much stronger equity base. The main caution is that the company still has a sizable liability stack and a large goodwill balance, so investors should watch whether the improved financial position translates into durable operating performance.

06/03/26 06:52 AM ETAI Generated. May Contain Errors.

ARM Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ARM's fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

ARM's net income appears to be on an upward trend, with a most recent value of $904 million in 2026, rising from $549 million in 2022. The previous period was $792 million in 2025. Check out ARM's forecast to explore projected trends and price targets.

ARM's total operating income in 2026 was $900 million, based on the following breakdown:
  • Total Gross Profit: $4.80 billion
  • Total Operating Expenses: $3.90 billion

Over the last 4 years, ARM's total revenue changed from $2.70 billion in 2022 to $4.92 billion in 2026, a change of 82.0%.

ARM's total liabilities were at $2.42 billion at the end of 2026, a 15.5% increase from 2025, and a 14.1% decrease since 2023.

In the past 3 years, ARM's cash and equivalents has ranged from $1.55 billion in 2023 to $2.75 billion in 2026, and is currently $2.75 billion as of their latest financial filing in 2026.

Over the last 4 years, ARM's book value per share changed from 0.00 in 2022 to 7.84 in 2026, a change of 784.3%.



Financial statements for NASDAQ:ARM last updated on 5/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners